Comparisons of pharmacokinetics and genetic polymorphisms between type 2 diabetic patients with and without edema conditions when treated with thiazolidinediones
Thesis (Ph.D.)--Chulalongkorn University, 2008
Saved in:
Main Author: | Wannakamol Sonsingh (Author) |
---|---|
Other Authors: | Duangchit Panomvana Na Ayudhya (Contributor), Wallaya Jongjaroenprasert (Contributor), Chulalongkorn University. Faculty of Pharmaceutical Sciences (Contributor) |
Format: | Book |
Published: |
Chulalongkorn University,
2013-07-03T08:09:51Z.
|
Subjects: | |
Online Access: | http://cuir.car.chula.ac.th/handle/123456789/32762 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Correlation between <i>PPARG</i> Pro12Ala Polymorphism and Therapeutic Responses to Thiazolidinediones in Patients with Type 2 Diabetes: A Meta-Analysis
by: Eun Jeong Jang, et al.
Published: (2023) -
Challenges in drug discovery for thiazolidinedione substitute
by: Jian-ping Ye
Published: (2011) -
Thiazolidinedione or Rhodanine: A Study on Synthesis and Anticancer Activity Comparison of Novel Thiazole Derivatives
by: Cigdem Ozen, et al.
Published: (2018) -
Novel thiazolidinedione analog reduces a negative impact on bone and mesenchymal stem cell properties in obese mice compared to classical thiazolidinediones
by: Andrea Benova, et al.
Published: (2022) -
Dexketoprofen Pharmacokinetics is not Significantly Altered by Genetic Polymorphism
by: Gina Mejía-Abril, et al.
Published: (2021)